Stockscreener 앱 받기
2.95%
시간 외 거래:
전일 마감가:
$336.23
열려 있는:
$336.23
하루 거래량:
3.13M
Relative Volume:
1.19
시가총액:
$176.21B
수익:
$37.30B
순이익/손실:
$7.80B
주가수익비율:
22.69
EPS:
14.3793
순현금흐름:
$8.60B
1주 성능:
-1.62%
1개월 성능:
-6.29%
6개월 성능:
-3.10%
1년 성능:
+20.10%
1일 변동 폭
$325.16
$336.23
1주일 범위
$325.16
$338.49
52주 변동 폭
$267.73
$391.29
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, NVS, AZN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
326.31 | 181.56B | 37.30B | 7.80B | 8.60B | 14.38 |
LLY
Lilly Eli Co
|
1,004.92 | 897.72B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
226.71 | 555.59B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
210.39 | 372.39B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
148.08 | 285.77B | 54.66B | 13.58B | 16.05B | 7.0171 |
AZN
Astrazeneca Plc
|
181.58 | 286.84B | 60.48B | 10.40B | 8.05B | 3.3297 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-21 | 개시 | Canaccord Genuity | Hold |
| 2026-03-10 | 개시 | Jefferies | Hold |
| 2026-02-20 | 개시 | Barclays | Equal Weight |
| 2026-01-20 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | 재개 | UBS | Buy |
| 2025-12-05 | 업그레이드 | Erste Group | Hold → Buy |
| 2025-11-24 | 재개 | Truist | Hold |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-09-03 | 재개 | Raymond James | Mkt Perform |
| 2025-05-20 | 재개 | Guggenheim | Neutral |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
Amgen Inc stock (US0311621009): lungs cancer setback meets steady biotech cash flow - AD HOC NEWS
Japan Flags 20 Deaths, Liver Injury Risk in Amgen's Rare Disease Drug Tavneos - Medical Dialogues
Amgen Inc. stock (US0311621009): focus on latest earnings and drug pipeline developments - AD HOC NEWS
Amgen (AMGN) Faces Scrutiny After Deaths Linked to Tavneos Thera - GuruFocus
Amgen’s Tavneos linked to 20 deaths in Japan (AMGN:NASDAQ) - Seeking Alpha
Stephens Inc. AR Grows Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. stock underperforms Friday when compared to competitors - MSN
Is trending stock Amgen Inc. (AMGN) a buy now? - MSN
Commerzbank Aktiengesellschaft FI Has $48.62 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Sells 3,513 Shares of Amgen Inc. $AMGN - MarketBeat
Applied Finance Capital Management LLC Acquires 3,069 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen’s Tavneos discouraged by Japanese partner after deaths - The Japan Times
Amgen’s rare disease drug linked to deaths, liver injuries in Japan, Kissei reports - WKZO
20 People in Japan Died After Taking Amgen Drug - WSJ
Amgen’s Tavneos Discouraged by Japanese Partner After Deaths - Bloomberg.com
Amgen's rare disease drug linked to deaths, liver injuries in Japan, Kissei reports - Reuters
Stocks to Watch Recap: Intel, Nvidia, Amgen, LVMH -- WSJ - Moomoo
Amgen stock falls after Kissei warns on Tavneos liver risks - Investing.com
Amgen Inc. stock (US0311621009): focus on Repatha growth as first-quarter 2026 results mix - AD HOC NEWS
Amgen Inc. (AMGN) is a trending stock: Facts to know before betting on it - MSN
Amgen Expands Data Demands From Providers Getting Drug Discounts - Bloomberg Law News
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Amgen Inc. $AMGN Stock Holdings Lessened by Thrivent Financial for Lutherans - MarketBeat
Conning Inc. Acquires 97,957 Shares of Amgen Inc. $AMGN - MarketBeat
Arbejdsmarkedets Tillaegspension Invests $24.26 Million in Amgen Inc. $AMGN - MarketBeat
FDA Approval for WEZLANA issued to AMGEN INC - Quantisnow
Amgen stock (US0311621009): weight-loss hopes and Prolia boost after Q1 numbers - AD HOC NEWS
Is It Time To Reassess Amgen (AMGN) After Strong Multi Year Share Price Gains - Yahoo Finance
ETFs Investing in Amgen Inc. Shs Cert Deposito Arg Repr 0.033333 Shs Stocks - TradingView
Standing Bone Strong: Introducing a New Awareness Symbol for Osteoporosis - Amgen
BioAge Labs, Inc. joins Amgen and Novo Nordisk to outline future obesity drug innovation at Fierce Biotech Week - Traders Union
Amgen Inc.: - marketscreener.com
Are Options Traders Betting on a Big Move in Amgen Stock? - Yahoo Finance
Oligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight - GlobeNewswire Inc.
AMGN Maintains Overweight Rating by Piper Sandler -- Price Targe - GuruFocus
Amgen stock (US0311621009): Piper Sandler cuts price target amid rare disease review - AD HOC NEWS
Amgen stock (US0311621009): Biotech leader navigates patent cliffs and pipeline momentum - AD HOC NEWS
Piper Sandler lowers Amgen stock price target on rare disease outlook - Investing.com
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $427 - Moomoo
VIRGINIA RETIREMENT SYSTEMS ET Al Has $14.47 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Rayburn West Financial Services LLC Acquires New Position in Amgen Inc. $AMGN - MarketBeat
Summit Wealth Group LLC Co. Has $386,000 Holdings in Amgen Inc. $AMGN - MarketBeat
Atria Investments Inc Buys 10,877 Shares of Amgen Inc. $AMGN - MarketBeat
A Look At Amgen (AMGN) Valuation After Q1 Beat Guidance Upgrade And US$300 Million US Expansion - simplywall.st
AMGN: Key products and pipeline assets drive growth, with major investments and strong Q1 results - TradingView
Amgen stock (US0311621009): Q1 earnings beat with revenue up 5.8% - AD HOC NEWS
Daiwa Securities Adjusts Price Target on Amgen to $390 From $410, Maintains Outperform Rating - marketscreener.com
Amgen stock (US0311621009): Q1 2026 earnings show net income turnaround - AD HOC NEWS
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
Amgen stock (US0311621009): Q1 2026 earnings beat estimates with revenue up 5.8% - AD HOC NEWS
Scientific Approach to Obesity - Amgen
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.88%
자본화:
|
볼륨(24시간):